Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MTEX
MTEX logo

MTEX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.130
Open
4.980
VWAP
5.04
Vol
5.65K
Mkt Cap
9.69M
Low
4.980
Amount
28.51K
EV/EBITDA(TTM)
--
Total Shares
1.93M
EV
7.28M
EV/OCF(TTM)
--
P/S(TTM)
0.09
Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.
Show More

Events Timeline

(ET)
2026-04-07
16:00:00
Mannatech Trading Halted Due to Volatility
select
2024-11-26 (ET)
2024-11-26
15:30:47
Mannatech names Robert Toth vice chairman of the board
select

News

seekingalpha
9.5
04-20seekingalpha
PinnedMannatech Reports Q4 Financial Results with Significant Losses
  • Financial Loss: Mannatech reported a Q4 GAAP EPS of -$5.94, indicating significant challenges in profitability and reflecting ongoing financial pressure on the company.
  • Revenue Decline: The company's Q4 revenue of $26.6 million represents an 8.3% year-over-year decrease, suggesting weakened market demand that could impact future business growth and investor confidence.
  • Deteriorating Cash Position: As of December 31, 2025, Mannatech's cash and cash equivalents fell to $6.2 million from $11.4 million as of December 31, 2024, highlighting increased liquidity risks that may limit operational flexibility.
  • Uncertain Future Outlook: Given the poor financial performance, Mannatech faces pressure to reassess its business strategy, and investors should monitor how the company addresses current financial challenges to restore growth.
Newsfilter
9.5
04-17Newsfilter
Mannatech Reports $15.2 Million Net Loss for 2025 Fiscal Year
  • Sales Decline: Mannatech reported fourth-quarter net sales of $26.6 million for 2025, an 8.2% decrease compared to the previous year, primarily due to the implementation of a new ordering system in North America that weakened sales momentum, indicating significant market pressure.
  • Gross Margin Erosion: The gross margin for 2025 fell to 74.9% from 77.6% in 2024, largely driven by supply chain challenges and rising product costs, highlighting the company's difficulties in maintaining cost control amid increasing expenses.
  • Increased Operating Loss: The company experienced an operating loss of $0.4 million in 2025, a stark contrast to the $1.4 million operating income in 2024, underscoring the challenges in operational efficiency in a deteriorating revenue environment.
  • Tightening Cash Flow: As of December 31, 2025, Mannatech's cash and cash equivalents decreased to $6.2 million from $11.4 million in 2024, indicating heightened liquidity risks and the need for improved financial management to navigate future uncertainties.
moomoo
9.5
04-17moomoo
MANNATECH ANNOUNCES FINANCIAL RESULTS FOR Q4 AND FULL YEAR 2025
  • Financial Results Overview: The financial results for the fourth quarter and year-end of 2025 have been reported, highlighting key performance metrics and overall financial health.

  • Revenue and Profit Trends: The report indicates trends in revenue and profit, showcasing growth or decline compared to previous periods.

  • Operational Highlights: Key operational achievements and challenges faced during the year are summarized, providing insight into the company's performance.

  • Future Outlook: The report concludes with a forward-looking statement, outlining expectations and strategic plans for the upcoming year.

Newsfilter
9.5
04-01Newsfilter
Mannatech Files for Extension on Annual Report Submission
  • Annual Report Delay: Mannatech has filed a Form 12b-25 with the SEC to delay the submission of its 2025 fiscal year annual report, originally due on March 31, 2026, now extended by 15 days to April 15, 2026.
  • Compliance Measures: By submitting Form 12b-25, Mannatech ensures adherence to SEC regulations, although this delay may impact investor confidence, the company is committed to filing the report promptly to maintain transparency.
  • Market Impact: This delay could negatively affect Mannatech's stock price, particularly as investor scrutiny on the company's financial health intensifies, potentially lowering market expectations for future growth.
  • Business Outlook: Operating in over 25 markets globally, Mannatech faces challenges from COVID-19 and increased competition, yet remains focused on driving growth through science-backed nutritional products, with upcoming financial reports serving as critical indicators of strategic execution.
Benzinga
9.5
2025-09-04Benzinga
American Eagle Shares Surge Nearly 23%; Check Out 20 Stocks Making Moves in Premarket Trading
  • American Eagle Outfitters Financial Results: American Eagle Outfitters, Inc. reported second-quarter revenue of $1.28 billion and earnings of 45 cents per share, both exceeding analyst expectations, leading to a 23.2% increase in share price during pre-market trading.

  • Other Notable Stock Movements: Several stocks saw significant pre-market trading movements, including BrilliA Inc. which rose 150.4%, and Bolt Projects Holdings, Inc. which gained 118%, while Neonode Inc. experienced a sharp decline of 80.2%.

  • Salesforce and Asana Performance: Salesforce Inc. and Asana, Inc. both reported better-than-expected second-quarter results, with Salesforce raising its FY2026 guidance despite a dip in share price, while Asana surged 7.8% after increasing its FY26 guidance.

  • Market Trends: The pre-market trading session showed a mix of gains and losses among various stocks, with notable declines in companies like C3.ai and GitLab Inc., which reported disappointing earnings and guidance.

NASDAQ.COM
9.5
2025-08-13NASDAQ.COM
Mannatech Inc. Q2 Loss Increases
  • Financial Performance: Mannatech Inc. reported a second-quarter loss of -$4.31 million, or -$2.27 per share, compared to a loss of -$0.62 million, or -$0.33 per share, in the same period last year.

  • Revenue Decline: The company's revenue decreased by 7.4% to $25.68 million from $27.74 million in the previous year.

Valuation Metrics

The current forward P/E ratio for Mannatech Inc (MTEX.O) is 9.57, compared to its 5-year average forward P/E of 0.51. For a more detailed relative valuation and DCF analysis to assess Mannatech Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.51
Current PE
9.57
Overvalued PE
2.45
Undervalued PE
-1.42

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding MTEX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Mannatech Inc (MTEX) stock price today?

The current price of MTEX is 5.02 USD — it has decreased -3.48

What is Mannatech Inc (MTEX)'s business?

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.

What is the price predicton of MTEX Stock?

Wall Street analysts forecast MTEX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTEX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Mannatech Inc (MTEX)'s revenue for the last quarter?

Mannatech Inc revenue for the last quarter amounts to 26.64M USD, decreased -8.18

What is Mannatech Inc (MTEX)'s earnings per share (EPS) for the last quarter?

Mannatech Inc. EPS for the last quarter amounts to USD, decreased -100.00

How many employees does Mannatech Inc (MTEX). have?

Mannatech Inc (MTEX) has 189 emplpoyees as of April 21 2026.

What is Mannatech Inc (MTEX) market cap?

Today MTEX has the market capitalization of 9.69M USD.